Antibodies against p erk1 2
Antibodies against p-ERK1/2 are specific molecular probes used to detect the phosphorylated forms of the extracellular signal-regulated kinases 1 and 2 (ERK1/2) in biological samples. These antibodies recognize the dual phosphorylation of ERK1/2 at the Thr202/Tyr204 (ERK1) and Thr185/Tyr187 (ERK2) residues, which is a key event in the activation of the ERK signaling pathway.
Lab products found in correlation
6 protocols using antibodies against p erk1 2
Induction of Inflammatory Responses
Adrenoceptor Modulation in Cellular Assays
Adipogenic Differentiation Pathway Modulation
Antibody and Reagent Sources
Investigating Molecular Mechanisms in Cancer
Antioxidant Activity and Signaling Assays
The HRP-conjugated secondary antibodies and enhanced chemiluminescence (ECL) kit for Western blot were purchased from Amersham Biosciences (Piscataway, NJ). AKF-PD (Lot No.090601) was synthesized by Sunshine Lake Pharma Co, Ltd. (Shenzhen, Guangdong, China). Losartan was from Merck & Co, Inc (Whitehouse Station, NJ). All other chemicals were from Sigma-Aldrich Ltd unless otherwise indicated.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!